The influence of race and comorbidity on the timely initiation of antiretroviral therapy among older persons living with HIV/AIDS

American Journal of Public Health

Volumn 104, Issue 11, 2014, Pages e135-e141

  Abara, Winston E ^a   Smith, Lerissa ^b   Zhang, Shun ^b   Fairchild, Amanda J ^c   Heiman, Harry J ^b   Rust, George ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AFRICAN AMERICAN; ANCESTRY GROUP; CAUCASIAN; COMORBIDITY; EPIDEMIOLOGY; FEMALE; HIV INFECTIONS; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA; TIME; UNITED STATES;

AFRICAN AMERICANS; ANTI-HIV AGENTS; COMORBIDITY; CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HIV INFECTIONS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; TIME FACTORS; UNITED STATES;

EID: 84907809894     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2014.302227     Document Type: Article

References (65)

1. Linley L, Prejean J, An Q, Chen M, Hall HI. Racial/ethnic disparities in HIV diagnoses among persons aged 50 years and older in 37 US States, 2005-2008. Am J Public Health . 2012;102(8):1527-1534.
2. Brooks JT, Buchacz K, Gebo KA, Mermin J. HIV infection and older Americans: the public health perspective. Am J Public Health . 2012;102(8):1516-1526.
3. Prejean J, Tang T, Hall HI. HIV diagnoses and prevalence in the southern region of the United States, 2007-2010. J Community Health. 2013;38(3):414-426.
4. Levy JA, Ory MG, Crystal S. HIV/AIDS interventions for midlife and older adults: current status and challenges. J Acquir Immune Defic Syndr. 2003;33(suppl 2):S59-S67.
5. Savasta AM. HIV: associated transmission risks in older adults - an integrative review of the literature. J Assoc Nurses AIDS Care. 2004;15(1):50-59.
6. Lindau ST, Leitsch SA, Lundberg KL, Jerome J. Older women's attitudes, behavior, and communication about sex and HIV: a community-based study. J Womens Health (Larchmt). 2006;15(6):747-753.
7. Centers for Disease Control and Prevention. HIV among older Americans. Available at: http://www.cdc.gov/hiv/risk/age/olderamericans. Accessed May 3, 2014.
8. High KP, Brennan-Ing M, Clifford DB, et al. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012;60(suppl 1):S1-S18.
9. Emlet CA. "You're awfully old to have this disease": experiences of stigma and ageism in adults 50 years and older living with HIV/AIDS. Gerontologist . 2006;46(6):781-790.
10. Lindau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med. 2007;357(8):762-774.
11. Adams M, Oye J, Parker T. Sexuality of older adults and the internet: from sex education to cybersex. Sexual Relationship Therap. 2003;18(3):405-425.
12. Centers for Disease Control and Prevention. Compendium of evidence-based HIV behavioral interventions. Available at: http://www.cdc.gov/hiv/prevention/research/compendium/rr/complete.html. Accessed May 3, 2014.
13. Abara W, Coleman JD, Fairchild AJ, Gaddist B, White J. A faith-based community partnership to address HIV/AIDS in the southern US: implementation, challenges, and lessons learned. J Relig Health. 2013;1-12. published online October 31, 2013.
14. Effros RB, Fletcher CV, Gebo K, et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis. 2008;47(4):542-553.
15. Grabar S, Weiss L, Costagliola D. HIV infection in older patients in the HAART era. J Antimicrob Chemother. 2006;57(1):4-7.
16. Perez JL, Moore RD. Greater effect of highly active antiretroviral therapy on survival in people aged > or =50 years compared with younger people in an urban observational cohort. Clin Infect Dis. 2003;36(2):212-218.
17. Adler WH, Baskar PV, Chrest FJ, Dorsey-Cooper B, Winchurch RA, Nagel JE. HIV infection and aging: mechanisms to explain the accelerated rate of progression in the older patient. Mech Ageing Dev. 1997;96(1-3):137-155.
18. Althoff KN, Justice AC, Gange SJ, et al. Virologic and immunologic response to HAART, by age and regimen class. AIDS. 2010;24(16):2469-2479.
19. Lederman MM, McKinnis R, Kelleher D, et al. Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase. AIDS. 2000;14(17):2635-2642.
20. Simone MJ, Appelbaum J. HIV in older adults. Geriatrics. 2008;63(12):6-12.
21. Nguyen N, Holodniy M. HIV infection in the elderly. Clin Interv Aging . 2008;3(3):453-472.
22. Manfredi R, Chiodo F. A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age. AIDS. 2000;14(10):1475-1477.
23. National Council of Aging. Healthy aging. Available at: http://www.ncoa.org/assets/files/pdf/FactSheet-HealthyAging.pdf. Accessed May 3, 2014.
24. Rodriguez-Penney AT, Iudicello JE, Riggs PK, et al. Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS Patient Care STDS . 2013;27(1):5-16.
25. Kilbourne AM, Justice AC, Rabeneck L, Rodriguez-Barradas M, Weissman S; VACS 3 Project Team. General medical and psychiatric comorbidity among HIV-infected veterans in the postHAART era. J Clin Epidemiol. 2001;54(12):S22-S28.
26. Orlando G, Meraviglia P, Cordier L, et al. Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients. HIV Med. 2006;7(8):549-557.
27. Shah SS, McGowan JP, Smith C, Blum S, Klein RS. Comorbid conditions, treatment, and health maintenance in older persons with human immunode ficiency virus infection in New York City. Clin Infect Dis. 2002;35(10):1238-1243.
28. Moore RD, Keruly JC, Bartlett JG. Improvement in the health of HIV-infected persons in care: reducing disparities. Clin Infect Dis. 2012;55(9):1242-1251.
29. Fleishman JA, Yehia BR, Moore RD, Gebo KA, Agwu AL; HIV Research Network. Disparities in receipt of antiretroviral therapy among HIV-infected adults (2002-2008). Med Care. 2012;50(5):419-427.
30. Hanna DB, Buchacz K, Gebo KA, et al. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis. 2013;56(8):1174-1182.
31. Pence BW, Ostermann J, Kumar V, Whetten K, Thielman N, Mugavero MJ. The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy. J Acquir Immune Defic Syndr. 2008;47(2):194-201.
32. Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009;23(1):41-49.
33. Meditz AL, MaWhinney S, Allshouse A, et al. Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection. J Infect Dis. 2011;203(4):442-451.
34. Gebo KA, Fleishman JA, Conviser R, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr. 2005;38(1):96-103.
35. King WD, Minor P, Ramirez Kitchen C, et al. Racial, gender and geographic disparities of antiretroviral treatment among US Medicaid enrolees in 1998. J Epidemiol Community Health. 2008;62(9):798-803.
36. Guwani JM, Weech-Maldonado R. Medicaid managed care and racial disparities in AIDS treatment. Health Care Financ Rev. 2004;26(2):119-132.
37. Lemly DC, Shepherd BE, Hulgan T, et al. Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care. J Infect Dis. 2009;199(7):991-998.
38. Oramasionwu CU, Skinner J, Ryan L, Frei CR. Disparities in antiretroviral prescribing for Blacks and Whites in the United States. J Natl Med Assoc. 2009;101(11):1140-1144.
39. Zhang S, Senteio C, Felizzola J, Rust G. Racial/ethnic disparities in antiretroviral treatment among HIV-infected pregnant Medicaid enrollees, 2005-2007. Am J Public Health . 2013;103(12):e46-e53.
40. Kaiser Family Foundation. Medicaid and HIV/AIDS. Available at: http://kff.org/hivaids/fact-sheet/medicaid-and-hivaids. Accessed May 3, 2014.
41. International Classification of Diseases, Ninth Revision, Clinical Modification. Hyattsville, MD: National Center for Health Statistics; 1980. DHHS publication PHS 80-1260.
42. Hammer SM, Saag MS, Schechter M, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA. 2006;296(7):827-843.
43. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27.
44. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-1139.
45. Health Resource and Services Administration. Area Health Resources Files. Available at: http://arf.hrsa.gov. Accessed May 2, 2014.
46. Centers for Disease Control and Prevention. HIV Surveillance Report 2011. Available at: http://www.cdc.gov/hiv/pdf/statistics-2011-HIV-Surveillance-Report-vol-23.pdf. Accessed May 2, 2014.
47. Hall HI, Frazier EL, Rhodes P, et al. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Intern Med. 2013;173(14):1337-1344.
48. Paz-Bailey G, Pham H, Oster AM, et al. Engagement in HIV care among HIV-positive men who have sex with men from 21 cities in the United States. AIDS Behav. 2014;18(suppl 3):348-358.
49. Aliyu MH, Blevins M, Parrish DD, et al. Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria. J Acquir Immune Defic Syndr. 2014;65(2):e41-e49.
50. Williams DR, Jackson PB. Social sources of racial disparities in health. Health Aff (Milwood) . 2005;24(2):325-334.
51. Johnson EN, Roediger MP, Landrum ML, et al. Race/ethnicity and HAART initiation in a military HIV infected cohort. AIDS Res Ther . 2014;11(1):10.
52. Zhang S, McGoy SL, Dawes D, Fransua M, Rust G, Satcher D. The potential for elimination of racial-ethnic disparities in HIV treatment initiation in the Medicaid population among 14 southern states. PLoS ONE. 2014;9(4):e96148.
53. Reif S, Whetten K, Thielman N. Association of race and gender with use of antiretroviral therapy among HIV-infected individuals in the Southeastern United States. South Med J. 2007;100(8):775-781.
54. Abara W, Heiman HJ. The Affordable Care Act and low-income persons living with HIV/AIDS: looking forward in 2014 and beyond. J Assoc Nurses AIDS Care. 2014;Epub ahead of print.
55. Izzedine H, Launay-Vacher V, Deray G. Renal tubular transporters and antiviral drugs: an update. AIDS. 2005;19(5):455-462.
56. Post FA, Moyle GJ, Stellbrink HJ, et al. Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study. J Acquir Immune Defic Syndr. 2010;55(1):49-57.
57. Busti AJ, Hall RG, Margolis DM. Atazanavir for the treatment of human immunodeficiency virus infection. Pharmacotherapy. 2004;24(12):1732-1747.
58. Tomilo DL, Smith PF, Ogundele AB, et al. Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers. Pharmacotherapy. 2006;26(3):341-346.
59. Yun LW, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune De fic Syndr. 2005;38(4):432-438.
60. Vranceanu AM, Safren SA, Lu M, et al. The relationship of posttraumatic stress disorder and depression to antiretroviral medication adherence in persons with HIV. AIDS Patient Care STDS. 2008;22(4):313-321.
61. Mugavero MJ, Norton W, Saag MS. Health care system and policy factors influencing engagement in HIV medical care: piecing together the fragments of a fractured health care delivery system. Clin Infect Dis. 2011;52(suppl 2):S238-S246.
62. Cunningham WE, Markson LE, Andersen RM, et al. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States. J Acquir Immune Defic Syndr. 2000;25(2):115-123.
63. Hoeymans N, Feskens EJ, van den Bos GA, Kromhout D. Age, time, and cohort effects on functional status and self-rated health in elderly men. Am J Public Health. 1997;87(10):1620-1625.
64. Eaton JW, Johnson LF, Salomon JA, et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med. 2012;9(7):e1001245.
65. Centers for Disease Control and Prevention. National HIV/AIDS strategy. Available at: http://www.cdc.gov/hiv/policies/nhas.html. Accessed May 2, 2014.